FJX1 can be a candidate diagnostic and prognostic biomarker for CRC patients; downregulation of FJX1 expression or neutralization of secretory FJX1 inhibited CRC cell proliferation and migration in vitro and is strongly associated with liver metastasis [26, 27]. This evidence concerns the gene FJX1 and colorectal carcinoma.